Fate Therapeutics, Inc. Insider Transactions
Purchase
Sell
Fate Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Bressi Jerome Charles
See Remarks |
Sell | 5,980 @ $1.55 | $9,269 | 270,203 | 01/10/2025 | 01/13/2025 | |
|
TAHL CINDY
See Remarks |
Sell | 5,654 @ $1.55 | $8,764 | 336,707 | 01/10/2025 | 01/13/2025 | |
|
Valamehr Bahram
CEO |
Sell | 8,705 @ $1.54 | $13,406 | 349,364 | 01/10/2025 | 01/13/2025 | |
|
Redmile Group, LLC
Director, 10 percent owner: |
Buy | 397,964 @ $1.68 | $668,580 | 12,884,277 | 12/20/2024 | 12/26/2024 | |
|
Redmile Group, LLC
Director, 10 percent owner: |
Sell | 341,633 @ $1.68 | $573,943 | 12,486,313 | 12/20/2024 | 12/26/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fate Therapeutics, Inc. FAQ's
The list of insiders at Fate Therapeutics, Inc. includes Redmile Group, LLC, Bressi Jerome Charles, TAHL CINDY, Valamehr Bahram.
Insiders have sold a total of 361,972 Fate Therapeutics, Inc. shares in the last 12 months for a total of 605,382 sold.
The following insiders have sold Fate Therapeutics, Inc. shares in the last 12 months: Redmile Group, LLC ($573,943), Bressi Jerome Charles ($9,269), TAHL CINDY ($8,764), Valamehr Bahram ($13,406),
Insiders have purchased a total of 397,964 Fate Therapeutics, Inc. shares in the last 12 months for a total of 668,580.
The following insiders have purchased Fate Therapeutics, Inc. shares in the last 12 months: Redmile Group, LLC ($668,580),